Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

An obesity expert weighs in on intriguing new data and new drugs that hold promise in the battle against a stubborn problem.

The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...

Ilant estimates that behavioral therapy can help many people lose up to 5% of their weight, anti-obesity medications can help ...

A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...

New-generation anti-obesity drug Wegovy, made by the same company that created Ozempic, is now available in France – but it will not be funded by the French social security system. Danish ...

The cost of taking weekly injections of popular anti-obesity medications liraglutide ... providing important new insights ...

The cost of taking weekly injections of popular anti-obesity medications ... providing important new insights into cost considerations surrounding surgical and drug treatment of obesity.

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.

Hoping your company will begin paying for anti-obesity medications ... diabetes had started taking GLP-1 drugs. DSV, a global transportation company based in New Jersey, had not put any ...